Detect Cardiomyopathy and Arrhythmia

Sponsored, no-charge genetic testing
and counseling for individuals suspected
of having a familial cardiomyopathy or arrhythmia








Improve diagnosis, risk stratification, and management

Identify at-risk family members — before a life-threatening event

Post-test genetic counseling available for patients in the US and select countries* offered at no charge

Program eligibility

This program is available to individuals in eligible countries suspected of having a familial cardiomyopathy or arrhythmia.

Genetic testing with Invitae

The Detect Cardiomyopathy and Arrhythmia program offers the Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel to test genes associated with inherited arrhythmia and cardiomyopathy conditions.

Sponsored genetic counseling

Individuals in the US, Canada & Australia tested through the Detect Cardiomyopathy and Arrhythmia program are eligible for post-test genetic counseling to help them understand their test results. To schedule an appointment, click below.     

How to order

1. Submit an order

To place your online order, click here and follow the on-screen prompts.

To place a paper-based order, download the paper order form (English I Portuguese I Spanish) and include it in the specimen box, or email the completed form to

2. Collect a specimen

Australian, Canadian, and US clinicians can order a blood, buccal, or saliva collection kit here. Clinicians in other eligible countries should refer to the country-specific section below for instructions on how to order a specimen collection kit in their region. 
Please view specimen and shipping requirements for important information. If you chose to do a paper-based order, include the completed paper order form in the box with the specimen.

3. Receive results

On average, results are available 10-21 days after Invitae receives the specimen. You will receive a notification email once the test results are ready.
Log in to view the status of your online order. 

Country-specific program materials:

United States, Canada, and Australia:
Test Requisition Form (English)
Informed Patient Consent (English - US only)
Informed Patient Consent (English -  Outside US)
Program Flyer (English)

Formulário de Solicitação em papel (Português)
Formulário de Consentimento Informado do Paciente (Português)
Folheto/Panfleto do Programa e Instruções para Pedidos no Brasil (Português)

Argentina, Chile, Colombia, Mexico:
Formulario de Solicitud de Prueba (Español)
Consentimiento Informado del Paciente (Español)
Folleto del Programa y Instrucciones de Pedido (Español)

All eligible countries
Informed Consent for Postmortem Samples (English)

Next steps and additional services

Broaden your search with re-requisition

If you don’t find answers with your initial order, 
Detect Cardiomyopathy and Arrhythmia includes one re-requisition within 90 days to genes within the original clinical area.

Simply log into your account, navigate to the order, and click "Add rerequisition”

Family variant testing for familial insights

If a positive result is identified, testing for your patient’s family members is available.

Simply follow the ordering instructions, selecting only the gene(s) you are interested in testing for the family member. The partner code will automatically be added with the order.

Are you a patient?

If you're a patient and believe you are eligible for this sponsored testing program, you have options:

Contact Genome Medical
(available in US only)

Schedule a genetic counseling session, by phone or video, with an expert who can review your testing options and place the order. There is a cost associated with the Genome Medical services, which may be covered under your health benefits.

Discuss the program with your doctor

If you already have a healthcare provider who can place this order, you can download this flyer (English | Portuguese | Spanish) to take to your own provider.

Find a local genetics provider

Search our genetics providers network to find a provider in your area. Please sign in, or create an account, to connect with our network of professionals. There may be a cost associated with the provider’s services.

Detect Cardiomyopathy and Arrhythmia is offered in partnership with the following sponsors:

US & Canada


Support every step of the way

Client Services

Available to answer your questions or help you through the testing process.

Clinical Support Services

Licensed, board-certified genetic counselors, ready to support you.

Genetic counseling

Individuals in Australia, Canada, and the US tested through this program are eligible for post-test sponsored genetic counseling to help them understand their test results.

Explore relevant advocacy organizations


About Invitae

Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae provides clinical-grade, medically actionable genetic information to answer essential health questions across all stages of life.


While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing is available in the US, Canada, Argentina, Australia, Brazil, Chile, Colombia, and Mexico. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.


*Genetic counseling services are available to patients in the US, Canada, and Australia


  1. Towbin JA et al. 2019 HRS Expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019. doi:10.1016/j.hrthm.2019.05.007
  2. Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72:e91-e220.
  3. Priori SG et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.. Heart Rhythm. 2013;10:1932-63.
  4. Gersh BJ et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary. J Am. Coll Cardiol. 2011;58:2703-38.
  5. Ackerman MJ et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Heart Rhythm. 2011;8;1308-39.
  6. Hershberger, RE et al. Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. J. Card. Fail. 2018;24,281-302.